Unicycive Therapeutics, Inc. |
Director |
Common Stock |
3.47M |
$2.86M |
$0.83 |
Jul 11, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |
GERON CORP |
Director |
Common Stock |
1.97K |
$4.49K |
$2.28 |
Dec 29, 2023 |
Direct |
Unicycive Therapeutics, Inc. |
Director |
Tranche C Warrants (right to buy) |
18.6M |
|
|
Jul 11, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |
Unicycive Therapeutics, Inc. |
Director |
Series A-2 Preferred Stock |
13.4M |
|
|
Jul 11, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |
Unicycive Therapeutics, Inc. |
Director |
Tranche A Warrants (right to buy) |
12.8M |
|
|
Jul 11, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |
Unicycive Therapeutics, Inc. |
Director |
Tranche B Warrants (right to buy) |
11.6M |
|
|
Jul 11, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |
GERON CORP |
Director |
Stock Option (right to buy) |
180K |
|
|
May 9, 2024 |
Direct |
Unicycive Therapeutics, Inc. |
Director |
Stock Options |
180K |
|
|
Sep 5, 2023 |
Direct |
Unicycive Therapeutics, Inc. |
Director |
Series A-1 Convertible Preferred Stock |
8.08K |
|
|
Mar 8, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |
Sierra Oncology, Inc. |
Director |
Common Stock |
0 |
|
$55.00 |
Jul 1, 2022 |
By: Vivo Opportunity Fund Holdings, L.P. |
Sierra Oncology, Inc. |
Director |
Series A Warrant |
0 |
|
|
Jul 1, 2022 |
By: Vivo Opportunity Fund Holdings, L.P. |
Sierra Oncology, Inc. |
Director |
Series B Warrant (Right to Purchase) |
0 |
|
|
Jan 26, 2022 |
By Vivo Opportunity Fund, L.P. |
Sierra Oncology, Inc. |
Director |
Stock Option (right to buy) |
0 |
|
|
Jul 1, 2022 |
Direct |
Unicycive Therapeutics, Inc. |
Director |
Series A-1 Preferred Stock |
0 |
|
|
Jul 11, 2023 |
By Vivo Opportunity Fund Holdings, L.P. |